Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AVANIR Pharmaceuticals Invites Investors to Its Second Fiscal Quarter 2005 Conference Call on May 16, 2005.


SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay.  -- AVANIR Pharmaceuticals (AMEX AMEX

See: American Stock Exchange
:AVN AVN Aviation
AVN Avenue
AVN Adult Video News
AVN Avascular Necrosis
AVN Atrioventricular Node
AVN Aviation Model (weather forecast model, now Global Forecast System)
AVN Air Vanuatu (ICAO code) 
) will webcast its quarterly conference call on Monday, May 16, 2005 at 1:30 p.m. Pacific/ 4:30 p.m. Eastern. The call will be webcast live through AVANIR's corporate website at http://www.avanir.com/ and will feature Dr. Gerald Yakatan, President and Chief Executive Officer, and Gregory P. Hanson, Vice President and Chief Financial Officer. A press release announcing the quarter's financial results will be released at market close the same day.

It is recommended that you go to AVANIR's website at least 10 minutes in advance of the webcast to download any applicable software. For those who cannot listen to the live broadcast, the online replay will be available for 90 days, and a phone replay will be available through May 23, 2005, by dialing 888-266-2081 (domestic) and 703-925- 2533 (international) and entering the passcode 703112.

AVANIR Pharmaceuticals is a drug discovery and development company focused on developing and commercializing novel therapeutic products for the treatment of chronic diseases. Our product candidates address therapeutic markets that include central nervous system and cardiovascular disorders, inflammation, and infectious disease Infectious disease

A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions.
. The Company's first commercialized product, Abreva(R), is marketed in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere.  by GlaxoSmithKline Consumer Healthcare and is the leading over-the-counter product for the treatment of cold sores cold sore: see herpes simplex. . Further information about AVANIR can be found at www.avanir.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 10, 2005
Words:226
Previous Article:Advance Nanotech Discusses Vision for Nanotechnology Industry; Company Sees Bright Future for Evolution of Global Nanotechnology.
Next Article:Possis Medical Appoints Chief Financial Officer and Vice President of Sales and Marketing.



Related Articles
Webcast Alert: AVANIR Pharmaceuticals Announces Its Second Quarter 2005 Conference Call Webcast.
AVANIR Pharmaceuticals Reports Second Quarter of Fiscal Year 2005 Results.
AVANIR Pharmaceuticals Reports Third Quarter Fiscal 2005 Financial Results.
AVANIR Pharmaceuticals Reports Fourth Quarter and Fiscal 2005 Year End Results.
AVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on Thursday, February 9, 2006.
AVANIR Pharmaceuticals Reports First Quarter of Fiscal Year 2006 Results.
AVANIR Pharmaceuticals Reports Second Quarter of Fiscal 2006 Financial Results.
AVANIR Pharmaceuticals Reports Third Quarter Fiscal 2006 Financial Results.
AVANIR Pharmaceuticals Reports Fourth Quarter Fiscal 2006 Financial Results.
AVANIR Pharmaceuticals Reports Second Quarter Fiscal 2007 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles